Vectura Group
VEC:LNLondon Stock Exchange (Main Market)
Overview
Company Profile
Vectura develops inhaled therapies principally for the treatment of respiratory diseases.
Classification
SectorHealthcare
ExchangeLondon Stock Exchange (Main Market)
BoardMain Market